Defrijet FCT 180 Tablet
By Defrijet
Rx
10 Tablet in a Strip

Composition
Deferasirox(180mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
July, 2026

liver
When it comes to your liver, caution should be exercised when using Defrijet FCT 180 Tablet. It's important to note that patients with liver disease may require a dose adjustment when taking this medication. Due to limited information available on its use in such cases, it is highly recommended to consult your doctor before starting treatment. Your doctor will assess the potential benefits against any risks involved to make an informed decision.

kidney
Defrijet FCT 180 Tablet may not be safe for patients with kidney disease. Consult your doctor before using to assess potential risks.

alcohol
Consuming alcohol with Defrijet FCT 180 Tablet may lead to unpleasant side effects and increased alcohol sensitivity. It is advised to avoid alcohol while taking this medication. Consult your doctor for more information.

driving
When taking Defrijet FCT 180 Tablet, be cautious when driving as it may reduce alertness, cause dizziness, or drowsiness. If you experience these symptoms, avoid driving for safety. It's uncertain how this medicine affects driving ability, so stay mindful of any impacts on concentration and reaction time.

pregnancy
During pregnancy, it is advised to avoid using Defrijet FCT 180 Tablet as it may have harmful effects on the developing baby. Your doctor will evaluate the benefits and risks before prescribing. Please consult your doctor for suitable alternatives.

breastfeeding
Defrijet FCT 180 Tablet is considered safe during breastfeeding based on limited data showing no significant risk to the baby. However, it's not typically recommended for lactating women due to insufficient information on its safety. Your doctor may prescribe it if the benefits outweigh the risks.
| Habit Forming | No |
| Chemical Class | Triazole & benzoate derivative |
| Therapeutic Class | - |
| Action Class | Iron chelating agents |
₹340
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
